Detalles de la búsqueda
1.
A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.
Br J Clin Pharmacol
; 89(1): 61-79, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326810
2.
Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
Rheumatology (Oxford)
; 61(6): 2682-2693, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559222
3.
Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts.
Clin Exp Rheumatol
; 40(11): 2018-2022, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35200120
4.
Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study.
Rheumatology (Oxford)
; 60(10): 4681-4690, 2021 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502493
5.
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease.
Rheumatology (Oxford)
; 60(8): 3778-3788, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33331946
6.
Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study.
Rheumatology (Oxford)
; 60(11): 5105-5116, 2021 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560301
7.
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.
Rheumatology (Oxford)
; 60(2): 785-801, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32810267
8.
Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate.
Rheumatology (Oxford)
; 59(9): 2325-2333, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859346
9.
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
Ann Rheum Dis
; 78(10): 1333-1338, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31196844
10.
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Lancet
; 388(10042): 343-355, 2016 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287832
11.
Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients.
Rheumatology (Oxford)
; 52(8): 1462-6, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23620560
12.
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Ann Intern Med
; 156(5): 329-39, 2012 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22393128
13.
Concomitant prednisone may alleviate methotrexate side-effects in rheumatoid arthritis patients.
BMC Rheumatol
; 7(1): 8, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198659
14.
What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis.
RMD Open
; 9(2)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116986
15.
Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial.
Trials
; 23(1): 494, 2022 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35710576
16.
Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials.
Arthritis Care Res (Hoboken)
; 74(6): 889-895, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253497
17.
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores.
Arthritis Care Res (Hoboken)
; 74(9): 1493-1499, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770421
18.
Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions.
Arthritis Res Ther
; 24(1): 74, 2022 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321739
19.
TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA).
BMJ Open
; 12(10): e064338, 2022 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216430
20.
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.
Arthritis Rheum
; 62(12): 3607-14, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20722020